Chemokine receptor anagonists, methods and use therefor

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.

Saved in:
Bibliographic Details
Main Author LULY JAY R.,NAKASATO YOSHISUKE,OHSHIMA ETSUO,HARRIMAN GERALDINE C. B.,CARSON KENNETH G.,GHOSH SHOMIR,ELDER AMY M.,MATTIA KAREN M
Format Patent
LanguageEnglish
Published 14.02.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
Bibliography:Application Number: CN200610105450